Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Respiratory Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120554282A reveals organic acid purification for Revefenacin intermediates. Achieve high purity and scalable manufacturing for respiratory drug supply chains.
Patent CN115286491A reveals a novel crystallization-based route for 2-[2-(6-bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene, offering superior purity and scalability for global supply chains.
Discover the advanced refining method for Ambroxol HCl in patent CN102516096B. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115572290A introduces a green one-pot method for Ipratropium Bromide, eliminating toxic TiCl4 and improving yield for cost-effective API manufacturing.
Patent CN104177253B details a novel route for 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid. Offers cost reduction and scalable supply for pharmaceutical partners.
Novel patent CN113264839A details a high-ee route to levo-terbutaline using tert-butyl sulfinamide, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN112341347A reveals a green synthesis of Ambroxol Hydrochloride using isatoic anhydride. Achieves high purity and yield without hazardous lithium aluminum hydride.
Advanced synthesis of Ambroxol Hydrochloride via methyl anthranilate. High yield, green chemistry, and cost-effective manufacturing for global pharmaceutical supply chains.
Advanced methylation process for Ipratropium Bromide achieving >98% yield. Green chemistry solution for reliable pharmaceutical intermediate supply chain optimization.
Patent CN115819487A details a novel 4-step synthesis of 16α-hydroxyprednisolone from tetraene acetate, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111944855B details a high-yield enzymatic route for (R)-1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethanol, offering superior stereoselectivity.
Novel 4-step route from 3,5-dihydroxyacetophenone avoids toxic reagents. Cost-effective, scalable production for global respiratory drug manufacturers.
Patent CN102617457A reveals a high-yield route for Roflumilast intermediates, eliminating column chromatography for significant cost reduction in API manufacturing.
Patent CN1127498C discloses selective PDE IV inhibitors with improved safety. We offer reliable supply of these respiratory drug intermediates.
Patent CN108101841B details a controlled hydrogenation method for Indacaterol, significantly reducing Impurity A and enhancing manufacturing efficiency for global supply chains.
Patent CN104496981B reveals a high-yield route for COPD drug intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical production.
Patent CN111072500B reveals a green 3-step synthesis for Ambroxol Hydrochloride. Discover cost reduction in API manufacturing and high-purity scalable routes.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Patent CN102180820B reveals a water-methanol recrystallization method achieving >99.5% purity for Fudosteine, offering significant cost and supply chain advantages for API manufacturers.
Discover a novel purification method for Indacaterol intermediates using m-chlorobenzoic acid, offering higher yield and purity for reliable API intermediate supply chains.